Acute effects of styrene inhalation on the neuroendocrinological system of rats and the different effects in male and female rats.
There have been several epidemiological and experimental studies about styrene from the neuroendocrinological viewpoint. Some reported that styrene exposure affected the neuroendocrinological system and enhanced prolactin (PRL) secretion, but others have denied those effects. It was assumed that styrene exposure caused depletion of dopamine (DA), which is a PRL inhibitor, and that, in consequence, the PRL level increased. However, not only DA but also many other factors control PRL secretion. Therefore, the mechanism of hypersecretion of PRL has not yet been clearly elucidated. In addition, effects of styrene on the female reproductive system have been reported, but the susceptibility needs to be further studied. Therefore, to investigate what causes hypersecretion of PRL and how different the susceptibility is in males and females, we studied acute effects of styrene exposure on the neuroendocrinological system in male and female rats. Immediately after exposure to 150 ppm styrene vapor for 10 days (8 h/day), male and female rats were killed, and blood and brain samples were collected. The styrene concentration in blood, hormones such as PRL, growth hormone (GH) and thyroid-stimulating hormone (TSH) in plasma and neurotransmitters in various brain regions were measured. The styrene concentration in the blood of female rats was higher than that in male rats, and the PRL level was significantly increased in female exposed rats compared with controls. No significant change was observed in male rats. We did not observe any significant changes in DA, 5-hydroxytryptamine (5-HT) or their metabolites. Because neurotransmitters were not affected in either male or female rats, the mechanism enhancing PRL secretion remains unclear. These results suggest that styrene exposure may cause hypersecretion of PRL and that the sensitivity to styrene exposure of the female may be higher than that of the male.
Umemura
Tomohiro
T
Department of Public Health, School of Medicine, Hokkaido University, Kita 15, Nishi 7, Kita-ku, 060-8638 Sapporo, Japan. ume@fmsrsa.fukui-med.ac.jp
Kurahashi
Norie
N
Kondo
Tomoko
T
Katakura
Yoko
Y
Sata
Fumihiro
F
Kawai
Toshio
T
Kishi
Reiko
R
D000280:Administration, Inhalation; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D005260:Female; D013006:Growth Hormone / Q000097:blood; D008297:Male; D009490:Neurosecretory Systems / Q000187:drug effects / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000378:metabolism; D011388:Prolactin / Q000097:blood*; D051381:Rats; D017208:Rats, Wistar; D012737:Sex Factors; D020058:Styrene / Q000097:blood / Q000493:pharmacokinetics / Q000633:toxicity*; D013972:Thyrotropin / Q000097:blood
D018377:Neurotransmitter Agents; D020058:Styrene; D011388:Prolactin; D013972:Thyrotropin; D013006:Growth Hormone